Authors: Seth, A Markee, J Hoering, A Sevin, A Sabath, DE Schmitz, RE Kuroda, MJ Lifton, MA Hirsch, MS Collier, AC Letvin, NL McElrath, J

Citation: A. Seth et al., Alterations in T cell phenotype and human immunodeficiency virus type 1 - Specific cytotoxicity after potent antiretroviral therapy, J INFEC DIS, 183(5), 2001, pp. 722-729

Authors: Malhotra, U Berrey, MM Huang, YJ Markee, J Brown, DJ Ap, S Musey, L Schacker, T Corey, L McElrath, MJ

Citation: U. Malhotra et al., Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection, J INFEC DIS, 181(1), 2000, pp. 121-131

Authors: Akridge, R Hladik, F Markee, J Alef, C Kelley, H Collier, A McElrath, MJ

Citation: R. Akridge et al., Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure, IMMUNOL LET, 66(1-3), 1999, pp. 15-19

Authors: Goh, WC Markee, J Akridge, RE Meldorf, M Musey, L Karchmer, T Krone, M Collier, A Corey, L Emerman, M McElrath, MJ

Citation: Wc. Goh et al., Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: Evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects, J INFEC DIS, 179(3), 1999, pp. 548-557